PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300 | -29.2% | 17,991 | +17.2% | 0.02% | -32.4% |
| Q2 2023 | $424 | +112.0% | 15,354 | +76.2% | 0.03% | +126.7% |
| Q1 2023 | $200 | +18.3% | 8,713 | -43.7% | 0.02% | +7.1% |
| Q4 2022 | $169 | -99.9% | 15,482 | -35.1% | 0.01% | -26.3% |
| Q3 2022 | $201,000 | -29.5% | 23,848 | -33.8% | 0.02% | -26.9% |
| Q2 2022 | $285,000 | +15.4% | 36,033 | +245.1% | 0.03% | +225.0% |
| Q1 2022 | $247,000 | – | 10,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,446,874 | $154,696,000 | 18.62% |
| Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $109,919,000 | 11.24% |
| BVF INC/IL | 3,754,095 | $168,484,000 | 6.32% |
| Tri Locum Partners LP | 341,650 | $15,333,000 | 5.02% |
| Twin Lakes Capital Management, LLC | 143,440 | $6,438,000 | 3.58% |
| COMMODORE CAPITAL LP | 210,600 | $9,452,000 | 3.29% |
| Altium Capital Management LP | 282,445 | $12,676,000 | 2.94% |
| Pinz Capital Management, LP | 196,000 | $8,796,000 | 2.65% |
| Opaleye Management Inc. | 330,222 | $14,820,000 | 2.46% |
| RTW INVESTMENTS, LP | 3,507,390 | $157,412,000 | 2.38% |